GENE ONLINE|News &
Opinion
Blog

IPO
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Experts Discuss What’s Next for Healthcare Innovation and Investment at ASGH
2021-12-02
Chinese Vaccine Maker Raises $240 Million in Hong Kong Debut
2021-11-08
Shanghai Startup Lands $325 Million Nasdaq IPO to Advance Phase 3 Assets
2021-11-02
Shanghai Startup Poised for $325M IPO on Nasdaq
2021-10-21
South Korea’s D&D Pharmatech Secures $51M Series C, Eyes 2022 IPO
2021-10-20
LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
Astellas Taps Dyno in $1.6+ Billion Deal to Develop AAV Gene Therapies
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!